{"id":8007,"date":"2023-04-13T18:40:13","date_gmt":"2023-04-13T16:40:13","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2023\/04\/Merck-Microbiotica-Collaboration-News-Release.pdf"},"modified":"2023-04-13T18:40:13","modified_gmt":"2023-04-13T16:40:13","slug":"merck-microbiotica-collaboration-news-release","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/microbiotica-announces-clinical-trial-collaboration-with-msd-to-evaluate-mb097-in-combination-with-keytruda-pembrolizumab-in-a-phase-1b-clinical-trial-in-melanoma\/merck-microbiotica-collaboration-news-release\/","title":{"rendered":"Merck Microbiotica Collaboration News Release"},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-8007","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n